Top Markets
Coin of the day
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Rankning i aktier #12782
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Aktiekurs
$5.87
Senast synkroniserad: 2022-11-08
Marknadsvärde
$550.43M
Förändring (1 dag)
1.03%
Förändring (1 år)
0.00%
Land
US
Handel Silverback Therapeutics, Inc. (SBTX)

Kategori

Aktiekurshistorik för Silverback Therapeutics, Inc. (SBTX)
Högsta slutkurs: $6.02 den 2022-11-01

Lägsta slutkurs: $33.40 den 2020-12-01
Aktiekurshistorik för Silverback Therapeutics, Inc. från 2020 till 2026
Årlig aktiekursutveckling
År Prestanda
2022 -10.00%
2021 -79.97%
2020 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$752.76 6.28%
CH